CTE.AX

Healthcare Diagnostics & Research

Cryosite Limited

A$1.15
+0.00 +0.00% today Live

Price History

Not enough data
Price chart data
DatePrice
Oct 5, 2026, live at 1:42 PM ET1.15

Key Stats

Market Cap
56.13M
Avg Volume
1,554
P/E (TTM)
28.75
EPS
A$0.04
52W High
A$1.40
52W Low
A$0.84
Div. Yield
0.0%

Valuation

P/B Ratio
11.62
P/S Ratio
3.36
EV/EBITDA
17.34
EV/Revenue
3.69
PEG Ratio
1.53

Margins

Gross Margin 62.4%
Operating Margin 18.8%
Net Margin 13.4%
EBITDA Margin 21.3%

Growth & Returns

Revenue Growth (YoY)
12.7%
Earnings Growth (YoY)
2.4%
Earnings Growth (QoQ)
4.9%
Return on Equity
61.7%
Return on Assets
8.7%

Liquidity & Leverage

Current Ratio
1.32
Quick Ratio
1.03
Debt / Equity
1.59
Total Cash
2.24M
Total Debt
7.72M

About

Cryosite Limited provides outsourced clinical trials logistic services in Australia. It operates through Ambient, cold, and frozen; Ultra-frozen and cryogenic; and Cord Blood segments. The Ambient, cold, and frozen segment provides good manufacturing practice (GMP) clinical trial materials, scheduled medicines, controlled drug storage, clinical ancillary supplies, medical devices, and commercial products with strict temperature requirements. The Ultra-frozen and cryogenic segment offers advanced therapy medicinal products (ATMPS), such as cell and gene therapies (CGT), cell therapies, mRNA-based medicines, biological samples, and research and development materials requiring high-integrity cold storage. The Cord Blood segment provides storage of cord blood cell and tissue samples for personal or directed therapeutic use by maintaining under validated chain-of-identity controls. It also offers reverse logistics services, secondary packaging, inventory management, and quality transportation and distribution solutions. Cryosite Limited was incorporated in 1999 and is based in South Granville, Australia.

www.cryosite.com